CA
ELV icon

Cullinan Associates’s Elevance Health ELV Stock Holding History

Cullinan Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,700
Closed -$508K – 199
2017
Q2 		$508K Sell
2,700
-50
-2% -$8.98K 0.04% 165
2017
Q1 		$455K Sell
2,750
-3,628
-57% -$577K 0.04% 168
2016
Q4 		$917K Hold
6,378
– – 0.08% 144
2016
Q3 		$799K Buy
6,378
+3,528
+124% +$456K 0.07% 147
2016
Q2 		$374K Buy
2,850
+500
+21% +$68.4K 0.03% 172
2016
Q1 		$327K Sell
2,350
-100
-4% -$13.4K 0.03% 173
2015
Q4 		$342K Hold
2,450
– – 0.03% 172
2015
Q3 		$343K Sell
2,450
-500
-17% -$75.1K 0.03% 187
2015
Q2 		$484K Sell
2,950
-200
-6% -$32K 0.04% 177
2015
Q1 		$486K Buy
+3,150
New +$448K 0.04% 176

Other funds holding ELV

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return